Truist Financial Corp Royalty Pharma PLC Transaction History

Truist Financial Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 20, 2024	SELL	$26.26 - $29.9 $268,140 - $305,308	-10,211 Reduced 43.09%	13,486 $355,000
Q1 2024 May 10, 2024	BUY	$27.46 - $31.33 $217,181 - $247,788	7,909 Added 50.1%	23,697 $719,000
Q4 2023 Feb 02, 2024	BUY	$26.21 - $29.22 $413,803 - $461,325	15,788 New	15,788 $443,000
Q1 2023 May 05, 2023	BUY	$32.77 - $39.4 $15,926 - $19,148	486 Added 1.27%	38,731 $1.4 Million
Q4 2022 Feb 17, 2023	SELL	$39.17 - $44.04 $340,113 - $382,399	-8,683 Reduced 18.5%	38,245 $1.51 Million
Q3 2022 Oct 26, 2022	BUY	$39.88 - $44.65 $1.36 Million - $1.52 Million	34,103 Added 265.91%	46,928 $1.89 Million
Q2 2022 Jul 22, 2022	BUY	$37.53 - $44.22 $140,549 - $165,603	3,745 Added 41.24%	12,825 $539,000
Q4 2020 Feb 18, 2021	BUY	$36.12 - $50.05 $327,969 - $454,454	9,080 New	9,080 $455,000

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.